Sechenov School
Home › Pharmacology › Echinocandins

Echinocandins

Echinocandins

For medical students2 min readUpdated 2026-10-10

Echinocandins are a class of semi-synthetic lipopeptides that selectively inhibit the synthesis of fungal cell wall components. These drugs have high safety profiles in humans and are used to treat severe systemic mycoses.

Chemical structureSemi-synthetic lipopeptides
Molecular targetβ-(1,3)-D-glucan synthase
Route of administrationParenteral only (IV)
Key representativesCaspofungin, micafungin, anidulafungin

Mechanism of Action and Target

Echinocandins target the fungal cell wall, which is composed of chitin, glycoproteins, and glucans. These drugs non-competitively inhibit the enzyme β-(1,3)-D-glucan synthase.

These drugs are safe for humans because mammalian cells lack a cell wall and do not possess this enzymatic target.

Classification and Spectrum of Activity

The class includes three main agents: caspofungin, micafungin, and anidulafungin. Their antimicrobial spectrum covers:

  1. Candida species — exhibit a fungicidal effect. They remain active even against strains resistant to other antifungals, including Candida glabrata and Candida krusei.
  2. Aspergillus species — exhibit a fungistatic effect, halting fungal growth.

General Pharmacokinetics and Safety

All echinocandins are administered exclusively parenterally due to poor oral bioavailability and lack of gastrointestinal absorption.

Clinical Applications of Representatives

Each agent has distinct clinical indications:

Mnemonic

Echino-CAND-ins hit CAND-ida and aspergillus by destroying the wall via glucan synthase, but are given IV only!

Frequently asked questions

Why are echinocandins not administered orally?

The drugs have very low oral bioavailability and are not absorbed from the gastrointestinal tract, requiring parenteral administration.

What is the difference in action between Candida and Aspergillus?

Against Candida species, echinocandins are fungicidal (kill the fungi), whereas against Aspergillus species, they are fungistatic (inhibit growth).

Does caspofungin require dosage adjustment in renal impairment?

No, dose adjustment of caspofungin is not required in patients with impaired renal function.

Go deeper

More topics in Pharmacology

Cholagogues: Classification, Mechanism of Action, and Clinical UseBeta-Blockers in Coronary Heart DiseaseAlpha-BlockersDrugs for Cerebrovascular DisordersPharmacotherapy of Ventricular ArrhythmiasAntituberculous DrugsMuromonab-CD3Vitamins PP and PPathogenesis of Atherosclerosis and the Role of LipidsHeavy Metal SaltsEstrogensVitamin C (Ascorbic Acid)Pharmacology →